Amgen Inc. (AMGN) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $162.42, down from yesterday’s close by -1.03%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.
Does this stock stack up well when compared to its peers in the industry space? Let’s take a look. Amgen Inc. (AMGN) currently trades with a market capitalization of $120.69 Billion. That value represents a market adjusting for revenues that have been falling by -1.14 % on a quarterly year/year basis as of the company’s last quarterly report.
The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For AMGN, the company currently has $3.36 Billion of cash on the books, which is offset by $3.8 Billion current liabilities. You can get a sense of how sustainable that is by a levered free cash flow of $10.08 Billion over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $3.08 on a per share basis this quarter. Perhaps, that suggests something about why 64.29% of the outstanding share supply is held by institutional investors.
We’ve taken a serious look at this stock from a fundamental perspective, but the tale of the tape may offer more hints about what lies under the surface. Looking at the stock’s movement on the chart, Amgen Inc. recorded a 52-week high of $184.21. It is now trading 21.79% off that level. The stock is trading $160.88 its 50-day moving average by -1.54%. The stock carved out a 52-week low down at $133.64.
In recent action, Amgen Inc. (AMGN) has made a move of +2.82% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 10.12, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 1.10% with $734.34 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of AMGN.